Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

被引：0

作者：

Akyildiz, Arif

Guven, Deniz Can

Koksal, Baris

Karaoglan, Beliz Bahar

Salim, Derya Kivrak

Sutcuoglu, Osman

Erciyestepe, Mert

Alan, Ozkan

Taban, Hakan

Yildirim, Nilgun

Sakalar, Teoman

Yazilitas, Dogan

Ismayilov, Rashad

On, Sercan

Aslan, Ferit

Demirci, Nebi Serkan

Kemal, Yasemin

Diker, Omer

Gullu, Ibrahim Halil

Aksoy, Sercan

机构：

[1] Hacettepe Univ Canc Inst, Ankara, Turkiye

[2] Med Oncol Soc Turkey, Istanbul, Turkiye

[3] Hlth Sci Univ Antalya Educ & Res Hosp, Antalya, Turkiye

[4] Etlik City Hosp Ankara, Ankara, Turkiye

[5] Prof Dr Cemil Tascioglu Hosp, Istanbul, Turkiye

[6] Marmara Univ Pendik Res & Training Hosp, Istanbul, Turkiye

[7] Firat Univ, Dept Med Oncol, Elazig, Turkiye

[8] Necip Fazil City Hosp, Dept Med Oncol, Kahramanmarai, Turkiye

[9] Ankara Etlik City Hosp, Ankara, Turkiye

[10] Hacettepe Univ, Ankara, Turkiye

[11] Ege Univ, Izmir, Turkiye

[12] Ankara Med Pk Hosp, Dept Med Oncol, Ankara, Turkiye

[13] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Oncol, Istanbul, Turkiye

[14] Ondokuz Mayis Univ, Liman, Turkiye

[15] Near East Univ Hosp, Dept Med Oncol, Cyprus, Turkiye

[16] Hacettepe Oncol Inst, Ankara, Turkiye

[17] Hacettepe Univ, Inst Oncol, Ankara, Turkiye

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e18004

引用

页数：1

共 50 条

[1] Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
Akyildiz, Arif
Guven, Deniz Can
Koksal, Baris
Karaoglan, Beliz Bahar
Kivrak, Derya
Ismayilov, Rashad
Aslan, Firat
Sutcuoglu, Osman
Yazici, Ozan
Kadioglu, Ahmet
Alan, Ozkan
Majidova, Nargiz
Erciyestepe, Mert
Ozcan, Erkan
Akdag, Goncagul
Taban, Hakan
Kaya, Ali Osman
Guliyev, Murad
Yildirim, Nilgun
Sakalar, Teoman
Yazilitas, Dogan
Unal, Caglar
On, Sercan
Biter, Sedat
Demirci, Nebi Serkan
Senler, Filiz Cay
Kemal, Yasemin
Halil, Omer Diker
Gullu, Ibrahim
Aksoy, Sercan
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (09) : 4991 - 4999
[2] A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
George Fountzilas
Anna Fragkoulidi
Anna Kalogera-Fountzila
Martha Nikolaidou
Mattheos Bobos
Julien Calderaro
Felipe Andreiuolo
Marios Marselos
Cancer Chemotherapy and Pharmacology, 2010, 65 : 649 - 660
[3] A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
Fountzilas, George
Fragkoulidi, Anna
Kalogera-Fountzila, Anna
Nikolaidou, Martha
Bobos, Mattheos
Calderaro, Julien
Andreiuolo, Felipe
Marselos, Marios
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 649 - 660
[4] Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
Bilici, Ahmet
Koca, Sinan
Karaagac, Mustafa
Aydin, Sabin Goktas
Eraslan, Emrah
Kaplan, Muhammed Ali
Ocak, Birol
Goksu, Sema Sezgin
Paydas, Semra
Akgul, Fahri
Derin, Sumeyye
Ergun, Yakup
Yekeduz, Emre
Erol, Cihan
Ozyukseler, Deniz Tataroglu
Demiray, Atike Gokcen
Karaca, Mustafa
Guc, Zeynep Gulsum
Menekse, Serkan
Cinkir, Havva Yesil
Gumusay, Ozge
Sakin, Abdullah
Ozkul, Ozlem
Demir, Hacer
Erdem, Dilek
Besiroglu, Mehmet
Unal, Olcun Umit
Acar, Ramazan
Koral, Lokman
Sahin, Suleyman
Sakalar, Teoman
Bahceci, Aykut
Ozveren, Ahmet
Gunaydin, Ulug Mutlu
Seker, Mehmet Metin
Sunar, Veli
Dal, Pinar
Artac, Mehmet
Turhal, Serdar
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8243 - 8253
[5] Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
Ahmet Bilici
Sinan Koca
Mustafa Karaagac
Sabin Goktas Aydin
Emrah Eraslan
Muhammed Ali Kaplan
Birol Ocak
Sema Sezgin Goksu
Semra Paydas
Fahri Akgul
Sumeyye Derin
Yakup Ergun
Emre Yekeduz
Cihan Erol
Deniz Tataroglu Ozyukseler
Atike Gokcen Demiray
Mustafa Karaca
Zeynep Gulsum Guc
Serkan Menekse
Havva Yesil Cinkir
Ozge Gumusay
Abdullah Sakin
Ozlem Ozkul
Hacer Demir
Dilek Erdem
Mehmet Besiroglu
Olcun Umit Unal
Ramazan Acar
Lokman Koral
Suleyman Sahin
Teoman Sakalar
Aykut Bahceci
Ahmet Ozveren
Ulug Mutlu Gunaydin
Mehmet Metin Seker
Veli Sunar
Pinar Dal
Mehmet Artac
Serdar Turhal
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 8243 - 8253
[6] Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study
Peng, Chen
Li, Xiaolin
Tang, Wenjie
Zhu, Wanqi
Yan, Peile
Chen, Jinlong
Zhang, Xueliang
Guo, Qiufen
Wu, Qian
Wang, Qian
Liu, Naifu
Ma, Anqun
Lu, Yuanyuan
Lv, Pengzhong
Liu, Jing
Xie, Peng
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
[7] Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
Iglesias, Leticia
Vilchez, Rocio
Aguin, Santiago
Garcia, Ramon
Pena, Carolina
Carral, Alberto
Huidobro, Gerardo
Molina, Aurea
Gomez, JESuS GARCiA
Covela, Marta
Costa, Marinha
Medina, Ana
ANTICANCER RESEARCH, 2025, 45 (03) : 1181 - 1191
[8] Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer
Shalata, Walid
Yakobson, Alexander
Dudnik, Yulia
Swaid, Forat
Ahmad, Mohammad Sheikh
Abu Jama, Ashraf
Cohen, Ahron Yehonatan
Agbarya, Abed
BIOMEDICINES, 2023, 11 (09)
[9] A retrospective study evaluating the efficacy of pembrolizumab for metastatic or locally recurrent head and neck cancer: A real-world experience
Pirruccello, Jonathan P.
Afzal, Muhammad Zubair
Palmer, John P.
Dore, Maura
Shirai, Keisuke
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[10] Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World Experience
Du, Yue
Fu, Rui
Levinsky, Justin T.
Kamalraj, Pabiththa
Chan, Kelvin K. W.
Parmar, Ambica
Eskander, Antoine
Smoragiewicz, Martin
CURRENT ONCOLOGY, 2023, 30 (10) : 8928 - 8935

← 1 2 3 4 5 →